Clinical Trial Update: Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial report on sequential therapy with Tenofovir Alafenamide (TAF) for patients with chronic hepatitis B, including treatment outcomes after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Stanford University | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2023-07-03